Purchase Order 75F40123P00431
Award Date 9/19/23
Potential Completion Date 4/25/24
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $21,480 firm fixed price purchase order to Arraystar Inc. to provide transfer RNA sequencing services. The contract has a period of performance from August 1, 2023 through July 31, 2024 and will be performed in Potomac, Maryland. No additional context was provided regarding the FDA's programs or use of the contracted sequencing services. The award was made directly to Arraystar Inc. as the prime contractor, with...
- This is a $3,654.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the U.S. Department of Health and Human Services (HHS), to Arraystar Inc. for "OTHER FUNCTIONS MICROARRAY SERVICE". Arraystar Inc. is a for-profit company that specializes in innovative tools and sample to data services for non-coding RNA research, including long non-coding RNAs (LncRNAs), microRNAs, circular RNAs, and transfer RNAs. This...
- The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $20,788 firm fixed price purchase order to Illumina, Inc. for MISEQ service contract. The contract will provide sequencing services to the FDA through August 2024, with performance taking place in San Diego, California. As the largest regulatory agency within HHS, the FDA works to protect public health through ensuring the safety and advancement of medical products. Illumina is a leading genomics company...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $212,705.80 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The purchase order is for Illumina MiSeq service contracts to support the FDA's microbial genomics program, which requires the maintenance of 10 MiSeq sequencing instruments to perform bacterial foodborne pathogen genome sequencing, targeted gene sequencing, and...
- The Department of Health and Human Services Food and Drug Administration awarded a $22,766 purchase order to Nanostring Technologies, Inc. for the procurement of Nanostring cassettes and reagents. The firm fixed price contract has a period of performance from August 15, 2023 through August 14, 2024 and will be performed in Silver Spring, Maryland. The award is set aside for total small businesses. As the prime contractor, Nanostring will provide its proprietary gene expression analysis...
- The Department of Health and Human Services Food and Drug Administration awarded a $56,042.50 firm fixed price purchase order to Firalis Molecular Precision SA for MIRNA whole transcriptome assay services in human plasma samples. Firalis, doing business as Firalis and a subsidiary of Firalis, will perform the requested microRNA whole transcriptome assays in human plasma samples to support FDA programs from July 2024 through November 2024. No major subcontractors or set aside designations were...
- <p>The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Firalis, a for-profit organization, for the project "Profiling microRNA Transcripts in Plasma Samples". The contract, which does not have a set-aside designation, has a potential value of $161,845.00 and a completion date of May 1, 2021. The contract was awarded on July 9, 2019 and the place of performance is Jefferson, AR 72079, USA.</p>
- The Department of Health and Human Services Food and Drug Administration awarded a $51,193.93 purchase order to Pacific Biosciences of California, Inc. for sequencing supplies. The firm fixed price contract runs from August 23, 2023 to February 19, 2024 and will be performed by Pacific Biosciences in West Menlo Park, California. The original solicitation sought sequencing supplies as described in Combined Synopsis Solicitation 75F40123Q-117934 to support the FDA's evaluation of new sequencing...
- The Department of Health and Human Services Food and Drug Administration awarded a $67,963.80 firm fixed price purchase order to Illumina, Inc. for corrective, remedial, repair, and preventive maintenance services for Illumina's MiSeq sequencing systems. The contract has a period of performance through February 28, 2025 and was awarded on December 12, 2019. No set-aside designation was used for this award to support the FDA's medical device evaluation programs through ongoing maintenance and...
- The Department of Health and Human Services Food and Drug Administration awarded a $136,975.00 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for MiSeq sequencing service agreements covering four instruments, with a performance period ending on March 8, 2023. Illumina has previously received prime federal awards from agencies like the National Institutes of Health and Department of Veterans...